Skip to main navigation Skip to search Skip to main content

Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia

  • Tiao Lai Huang*
  • , Chin Chuen Lin
  • , Rong Fu Chen
  • , Chien Te Lee
  • *Corresponding author for this work
  • Chang Gung University
  • Show-Chwan Memorial Hospital Taiwan

Research output: Contribution to journal › Journal Article › peer-review

6 Scopus citations

Abstract

We investigated the blood levels of mixed-lineage leukemia 1 (MLL1) mRNA and BDNF (brain derived neurotrophic factor) exon IV promoter on histone Histone 3 lysine 4 trimethylation (H3K4me3) in peripheral blood of patients with schizophrenia and controls. Over one year, 36 patients with schizophrenia and 32 controls were recruited. Psychiatric diagnoses were made based on DSM-IV criteria. Higher blood MLL1 mRNA and BDNF exon IV promoter on H3K4me3 levels were noted in patients with schizophrenia than in controls. The results showed that blood MLL1 mRNA and BDNF exon IV on H3K4me3 levels might be involved in the psychopathology of schizophrenia.

Original languageEnglish
Pages (from-to)207-209
Number of pages3
JournalPsychiatry Research
Volume243
DOIs
StatePublished - 30 09 2016

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Ireland Ltd

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • BDNF
  • H3K4me3
  • MLL1
  • Schizophrenia

Fingerprint

Dive into the research topics of 'Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia'. Together they form a unique fingerprint.

Cite this